| Mouse ovarian cancer models recapitulate the human tumor microenvironment and patient response to treatment E Maniati, C Berlato, G Gopinathan, O Heath, P Kotantaki, A Lakhani, ... Cell reports 30 (2), 525-540. e7, 2020 | 87 | 2020 |
| Cdt1 and Geminin in cancer: markers or triggers of malignant transformation C Petropoulou, P Kotantaki, D Karamitros, S Taraviras Front Biosci 13 (13), 4485-4494, 2008 | 76 | 2008 |
| Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion ER Murray, S Menezes, JC Henry, JL Williams, L Alba-Castellón, ... Cell Reports 38 (4), 2022 | 60 | 2022 |
| Licensing regulators Geminin and Cdt1 identify progenitor cells of the mouse CNS in a specific phase of the cell cycle M Spella, O Britz, P Kotantaki, Z Lygerou, H Nishitani, RG Ramsay, ... Neuroscience 147 (2), 373-387, 2007 | 50 | 2007 |
| Differential geminin requirement for proliferation of thymocytes and mature T cells D Karamitros, P Kotantaki, Z Lygerou, H Veiga-Fernandes, V Pachnis, ... The Journal of Immunology 184 (5), 2432-2441, 2010 | 36 | 2010 |
| Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors D Karamitros, AL Patmanidi, P Kotantaki, AJ Potocnik, T Bähr-Ivacevic, ... Development 142 (1), 70-81, 2015 | 35 | 2015 |
| The tumor microenvironment of clear-cell ovarian cancer MJ Devlin, R Miller, F Laforets, P Kotantaki, DW Garsed, R Kristeleit, ... Cancer Immunology Research 10 (11), 1326-1339, 2022 | 22 | 2022 |
| T cell proliferation and homeostasis: an emerging role for the cell cycle inhibitor geminin D Karamitros, P Kotantaki, Z Lygerou, D Kioussis, S Taraviras Critical Reviews™ in Immunology 31 (3), 2011 | 20 | 2011 |
| Life without geminin D Karamitros, P Kotantaki, Z Lygerou, H Veiga-Fernandes, V Pachnis, ... Cell Cycle 9 (16), 3201-3205, 2010 | 20 | 2010 |
| Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis-a short report DN Karatzas, K Xanthopoulos, P Kotantaki, A Pseftogas, K Teliousis, ... Cellular Oncology 39, 287-293, 2016 | 15 | 2016 |
| Reduced Geminin levels promote cellular senescence MS Iliou, P Kotantaki, D Karamitros, M Spella, S Taraviras, Z Lygerou Mechanisms of Ageing and Development 134 (1-2), 10-23, 2013 | 15 | 2013 |
| The expression of tumor suppressor gene Cyld is upregulated by histone deacetylace inhibitors in human hepatocellular carcinoma cell lines P Kotantaki, G Mosialos Cell biochemistry and function 34 (7), 465-468, 2016 | 14 | 2016 |
| Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer. Cancer Immunol Res 9, 665–681 (2021) O Heath, C Berlato, E Maniati, A Lakhani, C Pegrum, P Kotantaki, ... CIR-20-0968. Crossref| PubMed, 2021 | 6 | 2021 |
| Human 3D ovarian cancer models reveal malignant cell intrinsic and extrinsic factors that influence CAR T cell activity JD Joy, B Malacrida, F Laforets, P Kotantaki, E Maniati, R Manchanda, ... Cancer Research, 2024 | 3 | 2024 |
| Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments F Laforêts, P Kotantaki, B Malacrida, S Elorbany, R Manchanda, ... Iscience 26 (4), 2023 | 3 | 2023 |
| TGFβ-mediated targeting of the extracellular matrix enhances the migration and cytotoxicity of CAR-T cells in 3D models of ovarian cancer JD Joy, B Malacrida, F Laforets, P Kotantaki, E Maniati, S Hopkins, ... Cancer Research 82 (12_Supplement), 693-693, 2022 | 2 | 2022 |
| Abstract B079: Human 3D ovarian cancer models reveal malignant cell intrinsic and extrinsic factors that influence CAR-T cell activity JD Joy, B Malacrida, F Laforets, P Kotantaki, E Maniati, R Manchanda, ... Cancer Research 84 (5_Supplement_2), B079-B079, 2024 | | 2024 |
| Chemotherapy-induced extracellular matrix remodeling in HGSOC P Kotantaki, F Laforêts, E Maniati, C Berlato, A Malliouri, MJ Devlin, ... Cancer Research 83 (7_Supplement), 5957-5957, 2023 | | 2023 |
| 3D in vitro models uncover malignant cell intrinsic and extrinsic mechanisms of CAR-T cell resistance in high grade serous ovarian cancer JD Joy, B Malacrida, F Laforêts, P Kotantaki, E Maniati, S Hopkins, ... Cancer Research 83 (7_Supplement), 4576-4576, 2023 | | 2023 |
| Impact of ARID1A mutation on the tumor microenvironment of advanced clear cell ovarian cancer MJ Devlin, RS Kristeleit, J McDermott, E Maniati, F Laforêts, P Kotantaki, ... Cancer Research 81 (13_Supplement), 2748-2748, 2021 | | 2021 |